Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Trastuzumab + XELOX in Advanced Gastric Cancer
NCT01396707Phase 2Completed
- Sponsor
- Asan Medical Center
- Start
- Jun 2011
- Primary completion
- Nov 2018
- Modality
- Engineered Antibody Formats, Antibody Conjugates, Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 2 trial of trastuzumab in gastric cancer (GC), gastroesophageal junction adenocarcinoma, sponsored by Asan Medical Center. Started Jun 2011; status: completed.
02
Drugs
03
Conditions
gastric cancer (GC)gastroesophageal junction adenocarcinoma
Beyond the preview
Go deeper on NCT01396707.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01396707.